iFR Guided Coronary Artery Bypass Grafting Surgery
Launched by PRAKASH PUNJABI · Jul 4, 2019
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special measurement called iFR (which checks blood flow in the heart) can help improve the success of coronary artery bypass grafting (CABG) surgery. The goal is to see if using iFR measurements before surgery leads to better results for patients' bypass grafts one year after the operation, compared to the standard method of assessing blockages through an angiogram (a type of imaging test).
To take part in this study, participants need to be between 25 and 80 years old, be undergoing their first elective CABG surgery, and be able to understand and sign the consent form. The trial is currently recruiting a small group of patients, between 28 and 100, and is focused on gathering data from a single center. If you join, you’ll have your heart examined using iFR before your surgery, and the researchers will track your progress for one year afterward to see how well your bypass grafts are functioning. This study could provide valuable insights into improving heart surgery outcomes for future patients.
Gender
ALL
Eligibility criteria
- • INCLUSION CRITERIA
- • 1. Age of 25 to 80 years of age
- • 2. Willing to participate and able to understand, read and sign the informed consent form (ICF) before standard of care elective CABG surgery
- • 3. Undergoing isolated first-time elective CABG surgery
- • 4. Available pre-operative angiography data with iFR measurements done during the pre-operative angiography
- • EXCLUSION CRITERIA
- • 1. Emergency CABG surgery
- • 2. Ejection Fraction≤ 40%
- • 3. Severe valvular heart disease
About Prakash Punjabi
Prakash Punjabi is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative clinical studies. With a focus on integrity and excellence, the organization collaborates with leading researchers and healthcare professionals to develop and implement rigorous trial protocols across diverse therapeutic areas. Prakash Punjabi emphasizes patient safety, ethical standards, and regulatory compliance, ensuring that all trials are conducted with the highest level of quality and transparency. By fostering partnerships and leveraging cutting-edge methodologies, Prakash Punjabi aims to contribute to the development of groundbreaking therapies that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, Greater London, United Kingdom
Patients applied
Trial Officials
Prakash P Punjabi, MBBS,MCh,FRCS,FFST,FESC,FCCP
Principal Investigator
Imperial College Healthcare NHS Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials